🔴 Alzamend Neuro is trading 6.41% down today after filing a 98.4 million-share resale registration

Alzamend Neuro is trading 6.41% down at $1.46 after filing a registration statement covering the resale of up to 98,388,305 common shares.

• The shares may be issued upon conversion of up to 25,000 Series D convertible preferred shares held by Ault Lending.
• The unusually large potential share supply has intensified dilution and selling-pressure concerns for the micro-cap biotech.